Haili Biotechnology completes business registration change
Shanghai Haili Biotechnology (SSE:603718) announced that it has completed the industrial and commercial registration changes and the filing of the company's articles of association. This follows the approval of resolutions regarding the repurchase and cancellation of restricted stock and stock options from the 2023 incentive plan. The company's total share capital has decreased from 657,900,000 shares to 655,662,200 shares, and the registered capital decreased from CNY 657,900,000 to CNY 655,662,200. The company received a new business license from the Shanghai Market Supervision and Administration Bureau, with the registered capital and the total number of shares now aligning with the updated figures. The company's business scope includes manufacturing and sales of biological products.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Hile Bio-Technology publishes news
Free account required • Unsubscribe anytime